iExosomes loaded with oxaliplatin (OXA), a chemotherapeutic agent for the treatment of pancreatic ductal adenocarcinoma, and gal-9 small interfering RNA (siRNA) were delivered to the tumor sites of murine pancreatic cancer models. Here, LGALS9 is linked to neoplasm.